Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 15/20 | 0.66 |
| ▸ | PGR | P06401 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19032793 | 0.80 | CFTR (1.00) | CFTR | |
| SCHEMBL19032867 | 0.77 | CFTR (1.00) | CFTRPGRGAAKDM4EALDH1A1 | |
| SCHEMBL19032873 | 0.77 | CFTR (0.79) | CFTRPGR | |
| SCHEMBL19032882 | 0.77 | CFTR (0.80) | CFTRPGR | |
| SCHEMBL27426923 | 0.77 | CFTR (0.56) | CFTRHPGD | |
| SCHEMBL19032881 | 0.76 | CFTR (1.00) | CFTR | |
| SCHEMBL19032884 | 0.76 | CFTR (0.74) | CFTRGAAKDM4EALDH1A1LMNA | |
| SCHEMBL19032877 | 0.76 | CFTR (1.00) | CFTR | |
| SCHEMBL19032762 | 0.76 | CFTR (0.77) | CFTRPGRGAAKDM4EALDH1A1 | |
| SCHEMBL19032732 | 0.76 | CFTR (0.85) | CFTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11084795-B2 | CFTR regulators and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-08-10 | — | — | US | disclosed |
| US-20190031622-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190031622-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | CFTR, SLC26A4, CLCN2 | CFTR 1/4885PGR 3474/4885GAA 585/4885 |
| US-11084795-B2 | CFTR regulators and methods of use thereof | CFTR, SLC26A4, CLCN2 | CFTR 1/4885PGR 3474/4885GAA 585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.